Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: methodology of phase 3 randomized trial

  • Harrington, K.; 
  • Machiels, J. -P.; 
  • Shin, S. W.; 
  • Cohen, E.; 
  • Burtness, B.; 
  • 외 4명
제목
Pembrolizumab (MK-3475) versus standard treatment in patients with recurrent or metastatic head and neck cancer: methodology of phase 3 randomized trial
저자
Harrington, K.; Machiels, J. -P.; Shin, S. W.; Cohen, E.; Burtness, B.; Gause, C.; Swift, A.; Swaby, R.; Le Tourneau, C.
DOI
10.1093/annonc/mdv514.03
발행일
2015-11
학회명
Meeting of the European-Society-for-Medical-Oncology (ESMO)
개최지
Lausanne, SWITZERLAND
개최국가
영국
학회 개최일
2015-11-20 ~ 2015-11-21